Content Type: Research Publications

Pediatric Exclusivity Revenues for Cancer Drugs

March 6, 2026

Accelerating Biosimilar Market Access: The Case for Allowing Earlier Standing

March 6, 2026

Academic Detailing Interventions and Evidence-Based Prescribing: A Systematic Review

March 6, 2026

Strategies to Help Patients Navigate High Prescription Drug Costs

March 6, 2026

Impact of Priority Review Voucher Eligibility on Research and Development of Medical Countermeasures

March 6, 2026

Clinical Benefit and Revenues of Drugs Affected By Rare Pediatric Disease Priority Review Vouchers, 2017-2023

March 6, 2026

Association Between Changes in Prices and Out‐of‐Pocket Costs for Brand‐Name Clinician‐Administered Drugs

March 6, 2026

Multiple Myeloma Clinical Trials Exclude Patients with the Highest-Risk Disease: A Systematic Review of Trial Exclusion Criteria

March 6, 2026

The Long CON: an Empirical Analysis of Pharmaceutical Patent Thickets

March 6, 2026

Clearing Dense Drug-Patent Thickets

March 6, 2026

Use, Spending, and Prices of Adalimumab Following Biosimilar Competition

March 6, 2026

Characteristics of Academic Inventors on Government-Linked US Drug Patents

March 6, 2026